Gastric submucosal tumors and mesenchymal origin stromal tumors arise in the submucosa or muscularis propria of the gastric wall. They are classified as (i) neurogenic tumors –a) schwannomas b) granular cell tumors c) neurofibromas (ii) GIST and (iii) myogenic tumors- a) leiomyomas b) leiomyosarcomas. 6,11 GI neurogenic tumors are derived from autonomic components of Auerbach's plexus. The most common site for GIT Schwannoma is the stomach (60–70% of cases)6, followed by the colon and rectum. 1
GI schwannomas were initially reported by Daimaru et al 3. They have excellent prognosis after surgical resection.1,2, 3 Only one malignant case of GS7 and one related to Von Recklinghausen’s disease13have been reported. GS are frequently seen in the 5th to 8th decades with female predominance.1, 9, 10, 12 They can occur in children and, can be malignant rarely.8,10 They are usually asymptomatic or present with non-specific symptoms.8,9
Initial evaluation by upper GIT endoscopy may be normal or show non-specific findings such as extrinsic mass effect or ulceration.2 Since GS’s are submucosal tumours, endoscopic biopsy may not provide definite diagnosis.
CT is the mostly used imaging modality for gastric tumors, providing information for surgical planning by identifying the tumor, location, extent and relationship with neighbouring structures.8,9 GS appears as well circumscribed, spherical, ovoid or multilobulated solid hypodense mural tumors.8 Its characteristic CT feature is the homogeneous tumor attenuation due to lack of hemorrhage, cystic change, necrosis or degeneration within the tumors 1, 11 .They show mild enhancement in the arterial phase with progressively increasing enhancement in the venous and delayed phases.1,10 They rarely appear cystic, although large tumors may show cystic degeneration, and calcification is uncommon. 8
MRI shows low signal intensity on T1 weighted images and high signal intensity on T2-weighted images. Details about its internal features such as hemorrhage, necrosis or cystic changes and its relationship with the surrounding structures can be assessed .10
Fluoro-Deoxy Glucose (FDG)- PET is of limited value for the differentiation of GS and GIST, as the FDG uptake in them does not significantly differ. However, it can assess the recurrence or metastasis of malignant tumors. 10
GS should be differentiated from GIST, which may be malignant or have malignant potential.1 CT features of GIST depends on its size and aggressiveness. The most important feature for differentiation is the heterogeneous appearance with hypervascularity of GIST with hemorrhage, necrosis, and cystic change resulting in peripheral enhancement (in 92% of case). 1,6 However GS demonstrates homogeneously enhancement.1, 6 Smaller GISTs appear similar to GS on CT making it impossible to distinguish them by imaging alone12. However, GS is frequently exophytic or shows mixed growth pattern, homogeneous enhancement, perilesional lymph nodes and grow slower than GIST. 6,11 Final diagnosis is by histopathological and immunohistochemical examination.
Histologically, the pathognomonic feature of GIT schwannomas is a well circumscribed lesion surrounded by a cuff of lymphoid aggregates.9 They are spindle cell tumors with a microtrabecular pattern, peripheral lymphoid cuffing 2,6,9, lymphoplasmacytic infiltrate and occasional germinal centers.1,3,4 Spindle-shaped cells are noted in 70% of all GISTs and 20% contain epithelioid type or they can be pleomorphic. Immunohistochemistry is confirmatory for distinguishing GS and GIST. 6
Immunohistochemistry shows positive staining for S100 and vimentin and negative staining for smooth muscle actin and CD34 in neurogenic tumour.9 GISTs are mostly CD117-positive, CD34-positive, actin-positive, and S100-negative.6 In our case, the tumor cells were positive for S100 and negative for CD117, Actin and Desmin consistent with gastric neurogenic tumor. Lymphoid aggregation and presence of capsule highly suggested schwannoma rather than neurofibroma. Calretinin is a good marker to differentiate schwannomas and neurofibromas. 6
Other differential diagnosis are primary /secondary lymphomas and adenocarcinomas. Lymphomas show homogeneous CT attenuation before treatment, similar to GS. However, they are commonly associated with lymphadenopathy.1 Spiculated margins associated with regional adenopathy is seen in adenocarcinomas.1,11
The goal of surgery is to achieve R0 resection, including the lesion and any involved adjacent structures. Follow-up is not offered unless there are signs of malignant transformation. 9 The treatment for lesser curvature, middle and distal third gastric neoplasms is subtotal gastrectomy.6